5BXN
Target information
- RCSB PDB
- 5BXN
- Title
- Yeast 20S proteasome beta2-G170A mutant in complex with Bortezomib
- Method
- X-RAY DIFFRACTION
- Resolution
- 2.8
- Classification
- HYDROLASE/HYDROLASE INHIBITOR
- Organism
- Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
- Protein
- Proteasome subunit beta type-2 (P25043)
- Year
- 2018
- Publication Title
- Defective immuno- and thymoproteasome assembly causes severe immunodeficiency.
- Abstract
-
By N-ethyl-N-nitrosourea (ENU) mutagenesis, we generated the mutant mouse line TUB6 that is characterised by severe combined immunodeficiency (SCID) and systemic sterile autoinflammation in homozygotes, and a selective T cell defect in heterozygotes. The causative missense point mutation results in the single amino acid exchange G170W in multicatalytic endopeptidase complex subunit-1 (MECL-1), the β2i-subunit of the immuno- and thymoproteasome. Yeast mutagenesis and crystallographic data suggest that the severe TUB6-phenotype compared to the MECL-1 knockout mouse is caused by structural changes in the C-terminal appendage of β2i that prevent the biogenesis of immuno- and thymoproteasomes. Proteasomes are essential for cell survival, and defective proteasome assembly causes selective death of cells expressing the mutant MECL-1, leading to the severe immunological phenotype. In contrast to the immunosubunits β1i (LMP2) and β5i (LMP7), mutations in the gene encoding MECL-1 have not yet been assigned to human disorders. The TUB6 mutant mouse line exemplifies the involvement of MECL-1 in immunopathogenesis and provides the first mouse model for primary immuno- and thymoproteasome-associated immunodeficiency that may also be relevant in humans.
- External Link
- RCSB PDB
Ligand information
- HET
- BO2
- Chain ID
- H
- HET Number
- 301
- Molecular Formula
- C19H25BN4O4
- Structure
-
- IUPAC Name
- [(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid
- InChI
- InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1
- InChI Key
- GXJABQQUPOEUTA-RDJZCZTQSA-N
- Canonical SMILES
- CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O
- Bioactivity data
- CI006008
Covalent Binding
- Warhead
- Boronic Acid
- Reaction Mechanism
- Boronic Acid Addition
- Residue
- THR : 1
- Residue Chain
- H
- Interactions
- Pharmacophore Model